Top Markets
Coin of the day
Gencurix, Inc. Gencurix, Inc.

Gencurix, Inc.

229000
Rank in Stocks #28100
Gencurix Inc. provides diagnostic solutions in South Korea. Its products... Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
Share Price
$1.24
Market Cap
$29.13M
Change (1 day)
3.75%
Change (1 year)
8.90%
Country
KR
Trade Gencurix, Inc. (229000)

Category

Dividend history for Gencurix, Inc. (229000)
Gencurix, Inc. (stock symbol: 229000) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Gencurix, Inc. (229000) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors